Medivista Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.80 M
- Revenue Growth 70.47%
- Profit Growth -36.67%
- Ebitda 78.64%
- Net Worth 3.11%
- Total Assets -8.67%
About Medivista Lifesciences
Medivista Lifesciences Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 May 2015 (Nine years and eight months 21 days old ). Its registered office is in Panchkula, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.80 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Jatinder Bansal, Anita Bansal, and Nakul Bansal serve as directors at the Company.
Company Details
-
Location
Panchkula, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100HR2015PTC055513
-
Company No.
055513
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 May 2015
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Medivista Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jatinder Bansal
|
Director | 20-May-2015 | Current |
|
Anita Bansal
|
Director | 20-May-2015 | Current |
|
Nakul Bansal
|
Director | 20-May-2015 | Current |
Financial Performance of Medivista Lifesciences.
Medivista Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 70.47% increase. The company also saw a substantial fall in profitability, with a 36.67% decrease in profit. The company's net worth moved up by a moderate rise of 3.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medivista Lifesciences?
Unlock access to Medivista Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Onssss Hi-Tech Solutions (Opc) Private LimitedNakul Bansal is a mutual person
Charges (Loans)
₹0
₹0.80 M
Charges Breakdown by Lending Institutions
- Vijaya Bank : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jul 2016 | Vijaya Bank | ₹0.80 M | Satisfied |
How Many Employees Work at Medivista Lifesciences?
Unlock and access historical data on people associated with Medivista Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medivista Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medivista Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.